Project provides ~$4.7 million over 5 years to implement a platform for global teams engaged in model-based drug development
Simulations Plus Releases KIWI Version 1.5
A new modeling visualization experience
Simulations Plus Reports First Quarter FY2016 Financial Results
Consolidated net revenues up 18.4%; net income increased 109%
Simulations Plus Sets Date for 1st Quarter 2016 Earnings Release and Conference Call
Conference Call to be on Thursday, January 14, at 4:15 PM ET
Simulations Plus to Present at Two Upcoming Investor Conferences
Management to Present at LD Micro Conference in Los Angeles on December 2, and to Attend One-on-One Meetings at the Benchmark MicroCap Discovery Conference in Chicago on December 10
Simulations Plus Reports FY2015 and Fourth Quarter FY2015 Financial Results
Full Fiscal Year Pharmaceutical Software and Services Up 59.8%; Earnings per share $0.23 cents up $0.05 cents (22.4%) over prior year
Simulations Plus Sets Date for 4th Quarter and Fiscal Year 2015 Earnings Release and Conference Call
Conference Call to be on Wednesday, November 18, 2015, at 4:15 P.M. EST
Simulations Plus to Launch Major New Software Product
PKPlus™ Will Provide Analysis Capability Required for Regulatory Submissions
FDA’s Office of New Drug Products Places Order for 50 Additional Licenses to GastroPlus™
Additional Licenses Required to Meet Increasing Number of Submissions Utilizing GastroPlus
Simulations Plus Reports Preliminary Revenues for Fourth Quarter and Fiscal Year 2015
Company Reports Record Fourth-Quarter and Full-Year Revenues
Simulations Plus Awarded New Cooperative Agreement with FDA
Project to Support Enhancements to Company’s Industry-Leading GastroPlus™ Software
Simulations Plus Reports Third Quarter FY2015 Financial Results
Revenues up 58.9%, Net Income up 41.7%
Board declares dividend of $0.05/share
Simulations Plus Sets Date for 3rd Quarter 2015 Earnings Release and Conference Call
Conference call to be on Monday, July 13, 2015, at 4:15 p.m. EDT